This inventor holds 1 USPTO granted patent. Top assignee: The University of Melbourne. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Ines Swoboda: Innovator in Allergy Treatment
Introduction
Ines Swoboda is a prominent inventor based in Klagenfurt, Australia. She has made significant contributions to the field of immunotherapy, particularly in the treatment of allergic diseases. Her innovative work focuses on developing modified allergens that can effectively manage allergic reactions.
Latest Patents
Ines Swoboda holds a patent for a "Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity." This invention relates to reagents that are useful in the immunotherapeutic or immunoprophylactic treatment of allergic diseases. The modified allergens she developed exhibit reduced IgE interactivity, which leads to decreased IgE production-stimulatory activity while retaining T-cell antigenicity. This advancement is crucial for the immunomodulation of type I allergic disease conditions.
Career Highlights
Ines Swoboda is affiliated with the University of Melbourne, where she continues her research and development in allergy treatment. Her work has garnered attention for its potential to improve the quality of life for individuals suffering from allergies.
Collaborations
Ines collaborates with notable colleagues, including Nicole Deweerd and Mohan Bir Singh, who contribute to her research efforts and enhance the impact of her innovations.
Conclusion
Ines Swoboda's contributions to the field of allergy treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work is paving the way for more effective therapies for allergic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile